Xue-qun L. Luo
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.
Journal: Molecular genetics and metabolism reports
Published: March 02, 2026
Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort.
Journal: Pharmacoepidemiology and drug safety
Published: October 17, 2025
RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia.
Journal: The EMBO journal
Published: April 14, 2025
Landscape of paediatric oncology clinical trials in Asia.
Journal: EClinicalMedicine
Published: January 11, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group.
Journal: Therapeutic advances in hematology
Published: August 09, 2024
Editorial: Novel drug discovery and design in acute myeloid leukemia: from bench to bedside.
Journal: Frontiers in oncology
Published: June 15, 2024
The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.
Journal: Technology in cancer research & treatment
Published: January 05, 2024
Last Updated: 09/26/2026